BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 30276748)

  • 1. Proteases: Pivot Points in Functional Proteomics.
    Verhamme IM; Leonard SE; Perkins RC
    Methods Mol Biol; 2019; 1871():313-392. PubMed ID: 30276748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAILS proteomics reveals dynamic changes in airway proteolysis controlling protease activity and innate immunity during COPD exacerbations.
    Mallia-Milanes B; Dufour A; Philp C; Solis N; Klein T; Fischer M; Bolton CE; Shapiro S; Overall CM; Johnson SR
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1003-L1014. PubMed ID: 30284925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
    Eckhard U; Marino G; Butler GS; Overall CM
    Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.
    Huber-Lang M; Ekdahl KN; Wiegner R; Fromell K; Nilsson B
    Semin Immunopathol; 2018 Jan; 40(1):87-102. PubMed ID: 28900700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel 2-DE-Based Proteomic Analysis to Identify Multiple Substrates for Specific Protease in Neuronal Cells.
    Kim C; Oh YJ
    Methods Mol Biol; 2017; 1598():229-245. PubMed ID: 28508364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling protease activities by dynamic proteomics workflows.
    Klingler D; Hardt M
    Proteomics; 2012 Feb; 12(4-5):587-96. PubMed ID: 22246865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic techniques and activity-based probes for the system-wide study of proteolysis.
    auf dem Keller U; Schilling O
    Biochimie; 2010 Nov; 92(11):1705-14. PubMed ID: 20493233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics beyond trypsin.
    Tsiatsiani L; Heck AJ
    FEBS J; 2015 Jul; 282(14):2612-26. PubMed ID: 25823410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of protease dynamics in cutaneous wound healing by degradomics analysis of porcine wound exudates.
    Sabino F; Hermes O; Egli FE; Kockmann T; Schlage P; Croizat P; Kizhakkedathu JN; Smola H; auf dem Keller U
    Mol Cell Proteomics; 2015 Feb; 14(2):354-70. PubMed ID: 25516628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.
    Song R; Qiao W; He J; Huang J; Luo Y; Yang T
    J Med Chem; 2021 Mar; 64(6):2851-2877. PubMed ID: 33656892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches for dissecting protease functions to improve probe development and drug discovery.
    Deu E; Verdoes M; Bogyo M
    Nat Struct Mol Biol; 2012 Jan; 19(1):9-16. PubMed ID: 22218294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification.
    Huesgen PF; Overall CM
    Physiol Plant; 2012 May; 145(1):5-17. PubMed ID: 22023699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis to Identify Protease Substrates: Cleave to Decipher.
    Bhagwat SR; Hajela K; Kumar A
    Proteomics; 2018 Jul; 18(13):e1800011. PubMed ID: 29710386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics in plant protease substrate identification.
    Demir F; Niedermaier S; Villamor JG; Huesgen PF
    New Phytol; 2018 May; 218(3):936-943. PubMed ID: 28493421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring proteolytic processing events by quantitative mass spectrometry.
    Coradin M; Karch KR; Garcia BA
    Expert Rev Proteomics; 2017 May; 14(5):409-418. PubMed ID: 28395554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramembrane proteases as drug targets.
    Verhelst SHL
    FEBS J; 2017 May; 284(10):1489-1502. PubMed ID: 27889944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends and challenges in proteomic identification of protease substrates.
    Vizovišek M; Vidmar R; Fonović M; Turk B
    Biochimie; 2016 Mar; 122():77-87. PubMed ID: 26514758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Proteases Involved in Peptide Generation.
    Casteleiro MA; Stevens R; Klein J
    Methods Mol Biol; 2017; 1574():205-213. PubMed ID: 28315253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of transcriptomic analysis of all human proteases, non-proteolytic homologs and inhibitors: Organ, tissue and ovarian cancer cell line expression profiling of the human protease degradome by the CLIP-CHIP™ DNA microarray.
    Kappelhoff R; Puente XS; Wilson CH; Seth A; López-Otín C; Overall CM
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2210-2219. PubMed ID: 28797648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.